RT Journal Article
SR Electronic
T1 Effect of COVID-19 during pregnancy: Studying the maternal and neonatal outcomes and assessing the placental changes related to SARS-CoV-2
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.11.29.22282903
DO 10.1101/2022.11.29.22282903
A1 Madan, Surabhi
A1 Ramar, Dharshni
A1 Patel, Devang
A1 Shah, Nitesh
A1 Shah, Bhagyesh
A1 Thakkar, Vipul
A1 Shah, Hardik
A1 Chovatiya, Rashmi
A1 Dabhi, Pradip
A1 Patel, Minesh
A1 Patel, Amit
A1 Bapat, Nirav
A1 Bhatt, Parloop
A1 Naik, Aarya
A1 Rana, Manish
A1 Nayak, Himanshu
A1 Sharma, Karun Dev
YR 2022
UL http://medrxiv.org/content/early/2022/11/30/2022.11.29.22282903.abstract
AB Background Pregnant females affected with COVID-19 are reported to have poorer disease outcomes as compared to non-pregnant females of a similar age group. COVID-19 may lead to adverse changes in the placenta, which needs to be studied.Methods This is a case series of 63 pregnant women hospitalized with COVID-19 from May 2020 to February 2021.The primary outcomes were maternal death or complications.Results 63 women were studied. 83.3% of women were in the age group of 26 to 35 years. 33% women had associated comorbidities. 68.3% of women tested positive in their third trimester, 15.9% and 11% tested positive in their second and first trimesters respectively. 73% women had mild disease and 27% women required oxygen support. 3/63 women died. One woman in the second and two women in the third trimester died respectively. Histopathological examination in 13 placentae (of 19 placentae examined) were suggestive of maternal and fetal malperfusion.Conclusion Pregnant COVID-19 women may develop disease-related as well as obstetric complications.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of CIMS (Care Institute of Medical Sciences) hospital gave ethical approval for this work (CTRI/2020/05/025247).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors